| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611
K-ras oncogene mutation has been shown to be a frequent event in pancreatic ductal adenocarcinomas induced by the carcinogen N-nitroso-bis(2-oxopropyl)amine in the hamster. The present study examines the mutational status of the K-ras oncogene in lesions that precede the appearance of invasive ductal adenocarcinomas. Syrian golden hamsters (80100 g) received 12 weekly doses of 15 mg/kg N-nitroso-bis-(2-oxopropyl)amine and were serially sacrificed at 8, 12, 14, 16, or 24 weeks following the initiation of treatment. Ten µm-thick sections of formalin-fixed paraffin-embedded pancreas were examined for hyperplasia, papillary hyperplasia, carcinoma in situ, and invasive and metastatic ductal carcinoma. Marked lesions of interest were scraped from the slide, subjected to polymerase chain reaction-mediated amplification of the first exon of the K-ras gene, and probed by oligonucleotide-specific hybridization for mutations at codon either 12 or 13. Of 186 samples assayed, K-ras codon 12 mutations were detected in 26% of hyperplasias, 46% of papillary hyperplasias, 76% of carcinoma in situ, 80% of adenocarcinomas, and 43% of lymph node metastases. Codon 12 mutations were exclusively G to A changes at the second position. Codon 13 mutations were only detected in 9 of 168 samples. These results suggest that K-ras activation is an early event in N-nitroso-bis-(2-oxopropyl)amine-induced pancreatic carcinogenesis in the hamster.
1 This study was supported in part by NIH Grants CA34051, CA09560, and DK08574, and by the Marie A. Fleming and Edith M. Patterson Cancer Research Funds.
2 To whom requests for reprints should be addressed, at Department of Pathology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611.
Received 3/ 9/92. Accepted 6/ 8/92.
This article has been cited by other articles:
![]() |
J. Li, C. M. Weghorst, M. Tsutsumi, M. J. Poi, T. J. Knobloch, B. C. Casto, W. S. Melvin, M.-D. Tsai, and P. Muscarella Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors Carcinogenesis, February 1, 2004; 25(2): 263 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, D. L. Weddle, P. E. Thomas, B. Zheng, A. Castonguay, H. M. Schuller, and M. S. Miller Low Levels of Expression of Cytochromes P-450 in Normal and Cancerous Fetal Pancreatic Tissues of Hamsters Treated with NNK and/or Ethanol Toxicol. Sci., August 1, 2000; 56(2): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. CAPELLA, L. FARRE, A. VILLANUEVA, G. REYES, C. GARCI, G. TARAFA, and F. LLUIS Orthotopic Models of Human Pancreatic Cancer Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. VAN LAETHEM Ki-Ras Oncogene Mutations in Chronic Pancreatitis: Which Discriminating Ability for Malignant Potential? Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 210 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. J. Sturm, E. A. J. Rauws, R. H. Hruban, E. Caspers, T. B. Ramsoekh, K. Huibregtse, L. A. Noorduyn, and G. J. A. Offerhaus Clinical Value of K-ras Codon 12 Analysis and Endobiliary Brush Cytology for the Diagnosis of Malignant Extrahepatic BileDuct Stenosis Clin. Cancer Res., March 1, 1999; 5(3): 629 - 635. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |